FDA Attempts to Preempt By Rule

Our neighbors here on the network at the Products Liability Profs Blog have a pointer for the FDA’s attempt to preempt labeling claims via language in the preamble of a new rule.  As they note, this is part of an ongoing FDA effort to assert more exclusive control over pharmaceutical regulation.